Figures & data
Table 1. Antimalarial properties of marine cyanobacterial secondary metabolites.
Table 2. Morphological features of cyanobacterial species and their antiplasmodial activity against Pf3D7.
Table 3. Antiplasmodial potency, resistance and selectivity indices of potent cyanobacterial extracts.
Table 4. Biological activities of compounds produced by marine cyanobacteria.
Rickards RW, Rothschild JM, Willis AC, et al. (1999). Calothrixins A and B, novel pentacyclic metabolites from Calothrix cyanobacteria with potent activity against malaria parasites and human cancer cells. Tetrahedron 55:13513–20 Linington RG, Clark BR, Trimble EE, et al. (2009). Antimalarial peptides from marine cyanobacteria: Isolation and structural elucidation of gallinamide A. J Nat Prod 72:14–7 Tripathi A, Puddick J, Prinsep MR, et al. (2010a). Lagunamides A and B: Cytotoxic and antimalarial cyclodepsipeptides from the marine cyanobacterium, Lyngbya majuscula. J Nat Prod 73:1810–4 Gutiérrez M, Tidgewell K, Capson TL, et al. (2010). Malyngolide dimer, a bioactive symmetric cyclodepside from the panamanian marine cyanobacterium, Lyngbya majuscula. J Nat Prod 73:709–11 McPhail KL, Correa J, Linington RG, et al. (2007). Antimalarial linear lipopeptides from a panamanian strain of the marine cyanobacterium, Lyngbya majuscula. J Nat Prod 70:984–8 Tripathi A, Puddick J, Prinsep MR, et al. (2011). Lagunamide C, a cytotoxic cyclodepsipeptide from the marine cyanobacterium, Lyngbya majuscula. Phytochemistry 72:2369–75 Linington RG, González J, Urena L, et al. (2007). Venturamides A and B: Antimalarial constituents of the panamanian marine cyanobacterium Oscillatoria sp. J Nat Prod 70:397–401 Simmons TL, Engene N, Urena LD, et al. (2008). Viridamides A and B, lipodepsipeptides with antiprotozoal activity from the marine cyanobacterium, Oscillatoria nigro-viridis. J Nat Prod 71:1544–50 Clark BR, Engene N, Teasdale ME, et al. (2008). Natural products chemistry and taxonomy of the marine cyanobacterium Blennothrix cantharidosmum. J Nat Prod 71:1530–7 Papendorf O, Koenic GM, Wright AD. (1998). Hierridin b and 2,4-dimethoxy-6-heptadecyl-phenol, secondary metabolites from the cyanobacterium Phormidium ectocarpi with antimalarial activity. Phytochemistry 49:2383–6 Stolze SC, Deu E, Kaschani F, et al. (2012). The antimalarial natural product symplostatin 4 is a nanomolar inhibitor of the food vacuole falcipains. Chem Biol 19:1546–55 Desikachari TV. (1959). Cyanophyta. ICAR Monographs on Algae. New Delhi: Indian Council of Agricultural Research Balunas MJ, Linington RG, Tidgewell K, et al. (2010). Dragonamide E, a modified linear lipopeptide from Lyngbya majuscula with antileishmanial activity. J Nat Prod 73:60–6 Chang TT, More SV, Lu I, et al. (2011). Isomalyngamide A, A-1 and their analogs suppress cancer cell migration in vitro. Eur J Med Chem 46:3810–19 Gunasekera SP, Owle CS, Montaser R, et al. (2011). Malyngamide 3 and cocosamides A and B from the marine cyanobacterium Lyngbya majuscula from Cocos Lagoon, Guam. J Nat Prod 74:871–6 Tripathi A, Puddick J, Prinsep MR, et al. (2010b). Hantupeptins B and C, cytotoxic cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula. Phytochemistry 71:307–11 Montaser R, Abboud K, Paul VJ, Luesch H. (2011). Pitiprolamide, a proline-rich dolastatin16 analogue from the marine cyanobacterium Lyngbya majuscula from Guam. J Nat Prod 74:109–12 Iwasaki A, Teruya T, Suenaga K. (2010). Isolation and structure of koshikalide, a 14-membered macrolide from the marine cyanobacterium Lyngbya sp. Tetrahedron Lett 51:959–60 Thornburg CC, Thimmaiah M, Shaala LA, et al. (2011). Cyclic depsipeptides, grassypeptolides D and E and ibuepidemethoxylyngbyastatin 3, from a Red Sea Leptolyngbya cyanobacterium. J Nat Prod 74:1677–85 Malloy KL, Villa FA, Engene N, et al. (2011). Malyngamide2, an oxidized lipopeptide with nitric oxide inhibiting activity from a Papua New Guinea marine cyanobacterium. J Nat Prod 74:95–8